Search Ontology:
ChEBI
mirodenafil
- Term ID
- CHEBI:136049
- Synonyms
-
- 5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
- mirodenafil
- mirodenafilo
- mirodenafilum
- SK-3530
- SK3530
- Definition
- A member of the class of pyrrolopyrimidines that is 3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one having a 5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl group at positon 2, ethyl group at position 5, and a propyl group at position 7. It is a phosphodiesterase type 5 inhibitor which is used for the treatment of erectile dysfunction.
- References
-
- CAS:862189-95-5
- Chemspider:10173481
- DrugBank:DB11792
- Drug_Central:5005
- PMID:18098061
- PMID:19057138
- PMID:19095395
- PMID:19639551
- PMID:19929308
- PMID:20456834
- PMID:20649936
- PMID:20861845
- PMID:21162118
- PMID:21478894
- PMID:22692776
- PMID:22921287
- PMID:23006442
- PMID:23017527
- PMID:23303333
- PMID:23390072
- PMID:23700501
- PMID:23937271
- PMID:24219508
- PMID:24872948
- PMID:25162329
- PMID:25606563
- PMID:25833477
- PMID:26919966
- PMID:27034723
- PMID:32388784
- PMID:32981502
- Patent:KR20080062434
- Wikipedia:Mirodenafil
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from mirodenafil
Phenotype where environments contain mirodenafil
Phenotype modified by environments containing mirodenafil
Human Disease / Model Data
Citations